Venrock Healthcare Partners

Venrock Healthcare Partners

Venrock Healthcare Partners

FinSMEs

Sojournix Completes $44M Series C Financing

FinSMEs

Orchard Therapeutics Prices Initial Public Offering

Stock markets Health Costs
$200,000,000 IPO
PE Hub , FinSMEs

VC-backed Orchard Therapeutics goes public

Stock markets
$150,000,000 Venture capital (Series C)
FinSMEs

Orchard Therapeutics Raises $150M in Series C Financing

Funding Health
$60,000,000 IPO
PE Hub

VC-backed Constellation Pharmaceuticals rolls out IPO

Stock markets Funding Health
$65,000,000 Venture capital (Series C)
PE Hub , FinSMEs

Metacrine nabs $65 mln Series C

Messaging
$100,000,000 Venture capital
FinSMEs , PE Hub

Constellation Pharmaceuticals Raises $100M Financing

Funding Health Science
$110,000,000 Venture capital (Series B)
PE Hub

| Gene therapy developer Orchard Therapeutics raises $110 million: Reuters

Health Funding
$22,000,000 Venture capital (Series B)
PE Hub

| Metacrine scores $22 mln Series B

Xconomy

Metacrine Raises $22M to Advance New Drugs for Chronic Liver Disease

Funding Health Science
$20,000,000 Grant
FierceBiotech

Orchard gets $20M to trial ‘bubble boy’ gene therapy

£21,000,000 Venture capital (Series A)
b3cnewswire

Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies

$55,000,000 Venture capital
Xconomy

With Drugs in Clinic, Constellation Nabs $55M For IPO Push

Funding Health
Xconomy

Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal

Health
Xconomy

Metacrine Raises $36M in VC Funding, Focuses on Metabolic Diseases

Health Science Funding